Please select the option that best describes you:
When is it appropriate to use SBRT in treating lung metastases (oligomet, up to 3 mets etc.?)
What dose/fractionation is appropriate and does it differ between histology?
Answer from: Radiation Oncologist at Academic Institution
Patients with lung metastases rarely die directly from their pulmonary disease. Rather, systemic disease progression is typically the obstacle. Therefore, I would judge that the most critical question is not "how" to treat but "when" to treat. With limited clinical trials to guide management, this r...
Sign in or Register to read more